The Enterprise Value as of December 2025 (TTM) for Corcept Therapeutics Incorporated (CORT) is 8.79B

According to Corcept Therapeutics Incorporated’s latest financial reports and current stock price. The company's current Enterprise Value is 8.79B. This represents a change of 6.69% compared to the average of 8.24B of the last 4 quarters.

Corcept Therapeutics Incorporated (CORT) Historical Enterprise Value (quarterly & annually)

How has CORT Enterprise Value performed in the past?

The mean historical Enterprise Value of Corcept Therapeutics Incorporated over the last ten years is 2.03B. The current 8.79B Enterprise Value has changed 43.17% with respect to the historical average. Over the past ten years (40 quarters), CORT's Enterprise Value was at its highest in in the March 2025 quarter at 11.81B. The Enterprise Value was at its lowest in in the March 2016 quarter at 488.79M.

Corcept Therapeutics Incorporated (CORT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Corcept Therapeutics Incorporated Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Corcept Therapeutics Incorporated (CORT) Average Enterprise Value

How has CORT Enterprise Value performed in the past?

The current Enterprise Value of Corcept Therapeutics Incorporated (CORT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Corcept Therapeutics Incorporated (CORT) Enterprise Value vs. Peers

How is CORT’s Enterprise Value compared to its peers?

Corcept Therapeutics Incorporated’s Enterprise Value is greater than Halozyme Therapeutics, Inc. (8.49B), greater than Abivax S.A. (7.28B), greater than Rhythm Pharmaceuticals, Inc. (7.15B), greater than Merus N.V. (6.93B), greater than Cytokinetics, Incorporated (8.73B), less than Jazz Pharmaceuticals plc (9.90B), greater than Caris Life Sciences, Inc. (7.24B), greater than Axsome Therapeutics, Inc. (7.35B), greater than Nuvalent, Inc. (7.65B), less than Avidity Biosciences, Inc. (9.15B),

Build a custom stock screener for Corcept Therapeutics Incorporated (CORT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Corcept Therapeutics Incorporated using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Corcept Therapeutics Incorporated (CORT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Corcept Therapeutics Incorporated or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.